Advertisement

Veterinary Research Communications

, Volume 4, Issue 1, pp 83–98 | Cite as

Pharmacological aspects of hypersensitivity in domestic animals: A review

  • Peter Eyre
Article

Abstract

Hypersensitivities may be divided into (a) antibody-dependent, immediate-type reactions and (b) cell (lymphocyte)-mediated, delayed-type reactions. The former are mediated by a complex group of biochemical agents including biogenic amines, lipids and polypeptides. The latter class are mediated by a group of chemical agents known as lymphokines. This article describes the basic immunopharmacology of allergic reactions in mammals and further relates the fundamental phenomena to important clinical manifestations in domestic species. The classification of antiallergic drugs and their applications in the control of clinical allergic conditions are also reviewed.

Keywords

Public Health Lipid Polypeptide Clinical Manifestation Veterinary Medicine 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Ash, A.S.F., & Schild, H.O., 1966. Receptors mediating some actions of histamine. Br. J. Pharmac., 27: 427–439.Google Scholar
  2. Augstein, J., Farmer, J.B., Lee, T.B., Sheard, P. and Tattersall, M.C., 1973. Selective inhibitor of slow-reacting substance of anaphylaxis. Nature (New Biol.), 245: 215–217.Google Scholar
  3. Austen, K.F., 1974. Reaction mechanisms in the release of mediators of immediate hypersensitivity from human lung. Fed. Proc., 33: 2256–2262.Google Scholar
  4. Austen, K.F., & Orange, R.P., 1975. Bronchial asthma: The possible role of the chemical mediators of immediate hypersensitivity in the pathogenesis of subacute chronic disease. Am. Resp. Dis., 112: 423–436.Google Scholar
  5. Black, J.W., Duncan, W.A.M., Durant, C.J., Ganellin, C.R. and Parson, E.M., 1972. Definition and antagonism of histamine H2-receptors. Nature (Lond.), 236:385–390.Google Scholar
  6. Blood, D.C., Henderson, J.A., and Radostits, O.M., 1979. Diseases caused by allergy. In “Veterinary Medicine” 5th ed., Baillier-Tindall, London, Eds. Blood, Henderson and Radostits, pp. 1026–1034.Google Scholar
  7. Brimblecombe, R.W., Duncan, W.A.M., Durant, C.J., Emmett, J.C., Ganellin, C.R. and Parsons, M.E., 1975. Cimetidine — a non-thiourea H2-receptor antagonist. J. Int. Med. Res., 3: 86–92.Google Scholar
  8. Brink, C., Ridgeway, P. and Douglas, J.S., 1977. Modification of airway smooth muscle responses in the guinea pig by hydrocortisone. J. Pharmac. exp. Ther., 203: 1–11.Google Scholar
  9. Burka, J.F. & Eyre, P., 1974a. The immunolgical release of slow-reacting substance of anaphylaxis from bovine lung. Can. J. Physiol. Pharmacol., 52: 1201–1204.Google Scholar
  10. Burka, J.F. & Eyre, P., 1974b. A study of prostaglandins and prostaglandin antagonists in relation to anaphylaxis in calves. Can. J. Physiol. Pharmacol., 52: 942–951.Google Scholar
  11. Burka, J.F. & Eyre, P., 1976. Modulation of the release of SRS-A from bovine lung in vitro by several autonomic and autacoid agents. Int. Arch. Allergy Appl. Immunol, 50: 664–673.Google Scholar
  12. Burka, J.F. & Eyre, P., 1977. A pharmacological study of SRS-A on the bovine cutaneous vasculature. Can. J. Physiol. Pharmacol., 55: 904–908.Google Scholar
  13. Campbell, S.G., 1970. Milk allergy: An autoallergic disease in cattle. Cornell Vet., 60: 684–721.Google Scholar
  14. Chand, N. & Eyre, P., 1977. Non-steroidal anti-inflammatory drugs: a review. New applications in hypersensitivity of cattle and horses. Can. J. Comp. Med., 41: 233–240.Google Scholar
  15. Chand, N. & Eyre, P., 1978. Spasmolytic actions of histamine in airway smooth muscle of horse. Agents Actions, 8: 191–198.Google Scholar
  16. Cockcroft, D.W., Ruffin, R.E. & Hargreave, F.E., 1978. Effect of SCH 1000 in allergen-induced asthma. Clin. Allergy, 8: 361–372.Google Scholar
  17. Coombs, R.R.A. & Gell, P.G.H., 1968. Classification of allergic reactions responsible for clinical hypersensitivity and disease. InClinical Aspects of Immunology. (Eds. Gell, P.G.H. & Coombs, R.R.A., 1970) 2nd ed., p. 90, Blackwell, Oxford.Google Scholar
  18. Cox, J.S.G. & Altounyan, R.E.C., 1970. Nature and modes of action of sodium cromoglycate (Lumodal). Respiration, 27 (Suppl.): 292–309.Google Scholar
  19. DeWeck, A.L., 1972. Immunochemical mechanisms in drug allergy. InMechanisms in Drug Allergy (Eds. Dash, C.H. & Jones, H.E.H.) p. 2. Churchill Livingstone, London.Google Scholar
  20. Dickinson, E.O., Spencer, G.R. and Goreham, J.R., 1967. Experimental induction of an acute respiratory syndrome in cattle resembling bovine pulmonary emphysema. Vet. Rec., 80: 487–489.Google Scholar
  21. Eyre, P., 1971a. Pharmacology of bovine pulmonary vein anaphylaxisin vitro. Br. J. Pharmac., 43: 302–311.Google Scholar
  22. Eyre, P., 1971b. Release of dopamine from bovine lung by specific antigen and by compound 48/80. Br. J. Pharmac., 42: 423–427.Google Scholar
  23. Eyre, P., 1972. Release of 5-hydroxytryptamine from sensitized calf lung by antigen and by compound 48/80. Arch. Int. Pharmacodyn. Ther., 199: 245–252.Google Scholar
  24. Eyre, P., 1973. Dopamine receptors in the pulmonary vein of the calf. Res. Commun. Chem. Pathol. Pharmacol., 5: 27–34.Google Scholar
  25. Eyre, P. & Lewis, A.J., 1972. Production of kinins in bovine anaphylactic shock. Br. J. Pharmac., 44: 311–313.Google Scholar
  26. Eyre, P., Lewis, A.J. & Wells, P.W., 1973. Acute systemic anaphylaxis in the calf. Br. J. Pharmac., 47: 504–516.Google Scholar
  27. Eyre, P., Nymeyre, D.H., McCraw, B.M. & Deline, T.R., 1976. Protection by acetylsalicylic acid and other agents in experimental acute interstitial pneumonia in calves. Vet. Record, 98: 64–66.Google Scholar
  28. Flower, R.J., 1974. Drugs which inhibit prostaglandin biosynthesis. Pharmac. Rec., 26: 33–67.Google Scholar
  29. Geddes, B.A., Jones, T.R., Dvorsky, R.J., Lefcoe, N.M., 1974. Interaction of glurcocorticoids and bronchodilators on isolated guinea pig trachea and human bronchial smooth muscle. Am. Rev. Resp. Dis., 110: 420–427.Google Scholar
  30. Geddes, B.A. & Lefcoe, N.M., 1973. Respiratory smooth muscle relaxing effect of commercial steroid preparations. Am. Rev. Resp. Dis., 197: 395–399.Google Scholar
  31. Grieco, M.H. & Cushman, P., 1970. Adrenal glucocorticoids after twenty years. A review of their clinically relevant consequences. J. Chron. Dis., 22: 637–711.Google Scholar
  32. Ishizaka, K.T., 1968. Human reaginic antibodies and immunoglobulin E. J. Allergy, 42: 330.Google Scholar
  33. Ishizaka, T., Ishizaka, K., Orange, R.P. & Austen, K.F., 1971. Pharmacologic inhibition of the antigen-induced release of histamine and slow-reacting substance of anaphylaxis (SRS-A) from monkey lung tissues mediated by human IgE. J. Immun., 106: 1267–1273.Google Scholar
  34. Mulligan, W., Urquhart, G.M., Jennings, F.W. & Nielson, J.T.M., 1965. Immunological studies onN. brasiliensis infection in the rat The “self cure” phenomenon. Exptl. Parasit., 16: 341–349.Google Scholar
  35. Pemberton, D.H. & White, W.E., 1974. Bovine nasal granuloma. Austral. Vet. J., 50: 85–97.Google Scholar
  36. Piper, P.J., 1976. Release of active substances during anaphylaxis. Agents & Actions, 6/4: 547–550.Google Scholar
  37. Prime, F.J., 1971. Salbutamol: A review. Drugs, 1: 274–302.Google Scholar
  38. Riek, R.F., 1953. Studies on allergic dermatitis of the horse. Austral. Vet. J., 29: 177–184.Google Scholar
  39. Salem, H. & Jackson, R.H., 1974. Oral theophylline preparations. A review of their clinical efficacy in the treatment of bronchial asthma. Ann. Allergy, 32: 189–199.Google Scholar
  40. Samuelson, B., Borgeal, P., Hammarstrom, S. & Murphy, R.C., 1979. Introduction of a nomenclature: leukotrienes. Prostaglandins, 17: 785–787.Google Scholar
  41. Selman, I.E., Wiseman, A., Breeze, R.G., & Pirie, H.M., 1976. Fog fever in cattle: various theories on its etiology. Vet. Rec., 99: 181–184.Google Scholar
  42. Tizard, I.R., 1977.An Introduction to Veterinary Immunology. 1st Ed., W.B. Saunders Co, Philadelphia.Google Scholar
  43. Wanner, A., Zarzecki, S., Hirch, J. & Epstein, S., 1975. Tracheal mucous transport in experimental canine asthma. J. Appl. Physiol., 39: 950–957.Google Scholar
  44. Weisman, G. & Thomas, L., 1964. The effect of corticosteroids on connective tissue and lysosomes. Recent Progress Hormon. Res., 20: 215–245.Google Scholar
  45. Wilkie, B.N., 1976. Hypersensitivity pneumonitis: experimental production in calves with antigens ofMicropolyspora faeni. Can. J. Comp. Med., 40: 221–227.Google Scholar

Copyright information

© Elsevier Scientific Publishing Company 1980

Authors and Affiliations

  • Peter Eyre
    • 1
  1. 1.Pharmacology Laboratory, Department of Biomedical Sciences, Ontario Veterinary CollegeUniversity of GuelphGuelphCanada

Personalised recommendations